KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

Market Cap	170.14B
Revenue (ttm)	81.78B
Net Income (ttm)	2.99B
Shares Out	10.91M
EPS (ttm)	273.96
PE Ratio	56.94
Forward PE	n/a
Dividend	50.00 (0.32%)
Ex-Dividend Date	Dec 27, 2024

Volume	9,858
Average Volume	72,256
Open	15,240
Previous Close	15,230
Day's Range	14,910 - 15,240
52-Week Range	13,050 - 24,650
Beta	1.17
RSI	45.06
Earnings Date	n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 032300

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.